Caballero-Velázquez, T.; Pérez-López, O.; Yeguas Bermejo, A.; RodrÃguez ArbolÃ, E.; Colado Varela, E.; Sempere Talens, A.; Vidriales, M.B.; Solé-RodrÃguez, M.; Quirós Caso, C.; Pérez López, E.;
et al. Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study. Cancers 2023, 15, 1609.
https://doi.org/10.3390/cancers15051609
AMA Style
Caballero-Velázquez T, Pérez-López O, Yeguas Bermejo A, RodrÃguez Arbolà E, Colado Varela E, Sempere Talens A, Vidriales MB, Solé-RodrÃguez M, Quirós Caso C, Pérez López E,
et al. Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study. Cancers. 2023; 15(5):1609.
https://doi.org/10.3390/cancers15051609
Chicago/Turabian Style
Caballero-Velázquez, Teresa, Olga Pérez-López, Ana Yeguas Bermejo, Eduardo RodrÃguez ArbolÃ, Enrique Colado Varela, Amparo Sempere Talens, MarÃa Belén Vidriales, MarÃa Solé-RodrÃguez, Covadonga Quirós Caso, EstefanÃa Pérez López,
and et al. 2023. "Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study" Cancers 15, no. 5: 1609.
https://doi.org/10.3390/cancers15051609
APA Style
Caballero-Velázquez, T., Pérez-López, O., Yeguas Bermejo, A., RodrÃguez ArbolÃ, E., Colado Varela, E., Sempere Talens, A., Vidriales, M. B., Solé-RodrÃguez, M., Quirós Caso, C., Pérez López, E., Reinoso Segura, M., Prats-MartÃn, C., Montesinos, P., & Pérez-Simón, J. A.
(2023). Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study. Cancers, 15(5), 1609.
https://doi.org/10.3390/cancers15051609
